Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Oxygen-deprived tumor cells have survival advantage that promotes metastasis

Using cells from human breast cancers and mouse breast cancer models, researchers at the Johns Hopkins Kimmel Cancer Center say they have significant new evidence that tumor cells exposed to low-oxygen conditions have an advantage when it comes to invading and surviving in the bloodstream.

7 Nov 2019

Nanotechnologies can lead to big advances in cancer therapy

Nami Therapeutics Corporation, which gets its name from the Mandarin word for "nano," is committed to using nanotechnologies to make big advances in cancer therapy.

6 Nov 2019

3D-printed cell traps help researchers remove the hay to expose cancer cells

Finding a handful of cancer cells hiding among billions of blood cells in a patient sample can be like finding a needle in a haystack. In a new approach enabled by 3D-printed cell traps, researchers are removing the hay to expose the cancer cells.

28 Oct 2019

Genetically definable subgroups of cancers sensitive to treatment

Precision oncology aims to use genetic features of a patient's tumor to tailor anti-cancer therapy. DNA mutations in a drug target have provided a number of therapeutic opportunities; however, there are many cancer types that do not have obvious targetable mutations.

24 Oct 2019

Cooperative research center at LLNL aims to develop vaccines for chlamydia

A cooperative research center that aims to develop vaccines for chlamydia has been established by the National Institutes of Health at Lawrence Livermore National Laboratory.

24 Oct 2019

Cleveland Clinic announces Top 10 Medical Innovations for 2020

A dual-acting osteoporosis drug. Minimally invasive mitral valve surgery. New treatment for peanut allergies. These are some of the innovations that will enhance healing and change healthcare in the coming year, according to a distinguished panel of doctors and researchers.

23 Oct 2019

Yale scientists build powerful genomic research platform to study cervical cancer

Yale Cancer Center scientists have built a powerful genomic research platform to study cervical cancer, a disease that often is untreatable if it progresses after surgery or primary chemo-radiation treatment.

17 Oct 2019

Chemists find new way to synthesize most common molecule arrangement in medicine

Organic chemists at The Ohio State University have figured out how to synthesize the most common molecule arrangement in medicine, a scientific discovery that could change the way a number of drugs - including one most commonly used to treat ovarian cancer - are produced.

17 Oct 2019

Marshall receives $17 million renewal funding for biomedical research efforts in West Virginia

Marshall University Joan C. Edwards School of Medicine has received a five-year, $17 million award from the National Institutes of Health for continued funding of West Virginia IDeA Network of Biomedical Research Excellence.

15 Oct 2019

Combination of two drugs disrupts cancer cells' ability to survive DNA damage, study finds

In continuing efforts to find novel ways to kill cancer cells, researchers at the University of Maryland School of Medicine have identified a new pathway that leads to the destruction of cancer cells.

14 Oct 2019

New UW center awarded NIH funding to improve prevention and detection of cancer

Even successful methods for diagnosing, treating and caring for people who are suffering from cancer are not enough without effective, practical tools and guidance for putting those methods into practice.

11 Oct 2019

Multi-gene testing at point of diagnosis can save all women with breast cancer

A lifetime model evaluating the financial, health and social impact of multi-gene testing (BRCA1/2/PALB2) at diagnosis for all breast cancer patients was found to be extremely cost effective for both UK and US health systems.

3 Oct 2019

Innovative compound kills cancer cells, minimizes damage to normal tissues

Most of the current clinical anti-tumor drugs used in chemotherapy move around in the patient's blood after intake and are unable to pinpoint the targeted tumor. As a result, while killing the tumor cells, the healthy cells may also be killed as "collateral damage", leading to undesired side effects.

3 Oct 2019

Targeted therapy slows disease progression and improves survival for prostate cancer

A new PARP-inhibitor has been shown to significantly delayed cancer progression among patients with prostate cancer who had cancer cells with faulty DNA repair genes.

2 Oct 2019

Domestic violence may affect mothers' breastfeeding practices in developing countries

Mothers who have suffered from domestic violence are substantially less likely to follow recommended breastfeeding practices in low to middle-income countries, a new study shows.

1 Oct 2019

Breast, ovarian cancer drug more effective than targeted hormone therapy in some men with prostate cancer

A drug used for breast and ovarian cancer is more effective than modern targeted hormone treatments at slowing progression and improving survival in some men with advanced prostate cancer, phase III clinical trial findings reveal.

30 Sep 2019

Intensive new combination therapy for ovarian cancer shows promising results

Researchers have found that more intensive chemotherapy maintenance for ovarian cancer could be beneficial for patients. The results of the study were presented at the ESMO Congress 2019 in Barcelona, Spain last weekend on the 28th of September.

30 Sep 2019

Novel therapeutic approach improves survival in patients newly diagnosed with advanced ovarian cancer

An international study demonstrates that administering niraparib after conventional chemotherapy treatment in patients newly diagnosed with advanced ovarian cancer, improves their progression-free survival, and reduces their risk of relapse or death from this disease.

28 Sep 2019

PARP inhibitor combined with chemotherapy increases survival for newly diagnosed ovarian cancer patients

Researchers from The University of Texas MD Anderson Cancer Center reported study results showing that initial treatment with the PARP inhibitor veliparib in combination with chemotherapy significantly increased progression-free survival for patients with newly diagnosed, metastatic high-grade serous ovarian cancer, according to the results of the VELIA trial.

28 Sep 2019

Newly synthesized anticancer compound can block cancer signaling mechanism

Of the various different functions that proteins perform in a cell, a crucial one is the recognition and transmission of certain "signals," collectively referred to as signal transduction.

24 Sep 2019

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Oxygen-deprived tumor cells have survival advantage that promotes metastasis

Nanotechnologies can lead to big advances in cancer therapy

3D-printed cell traps help researchers remove the hay to expose cancer cells

Genetically definable subgroups of cancers sensitive to treatment

Cooperative research center at LLNL aims to develop vaccines for chlamydia

Cleveland Clinic announces Top 10 Medical Innovations for 2020

Yale scientists build powerful genomic research platform to study cervical cancer

Chemists find new way to synthesize most common molecule arrangement in medicine

Marshall receives $17 million renewal funding for biomedical research efforts in West Virginia

Combination of two drugs disrupts cancer cells' ability to survive DNA damage, study finds

New UW center awarded NIH funding to improve prevention and detection of cancer

Multi-gene testing at point of diagnosis can save all women with breast cancer

Innovative compound kills cancer cells, minimizes damage to normal tissues

Targeted therapy slows disease progression and improves survival for prostate cancer

Domestic violence may affect mothers' breastfeeding practices in developing countries

Breast, ovarian cancer drug more effective than targeted hormone therapy in some men with prostate cancer

Intensive new combination therapy for ovarian cancer shows promising results

Novel therapeutic approach improves survival in patients newly diagnosed with advanced ovarian cancer

PARP inhibitor combined with chemotherapy increases survival for newly diagnosed ovarian cancer patients

Newly synthesized anticancer compound can block cancer signaling mechanism

Pharmaceutical Manufacturing - Industry Focus eBook eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in